AK

Aditya Kulkarni

Founder & Chief Scientific Officer at Avammune Therapeutics

No bio yet


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Avammune Therapeutics

Avammune Therapeutics is a drug discovery company focused on immuno-oncology and especially the STING pathway. Avammune is developing a multimodal approach to modulate the STING pathway to treat cancer. Their multimodal approach employs a combination of engineered viruses and small molecules.


Employees

11-50

Links